BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Li X, Zhangsun D, Yu G, Su R, Luo S. The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain. Mar Drugs 2019;17:E265. [PMID: 31060282 DOI: 10.3390/md17050265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu X, Yuan M, Wang H, Zhangsun D, Yu G, Che J, Luo S. Novel αO-conotoxin GeXIVA[1,2] Nonaddictive Analgesic with Pharmacokinetic Modelling-Based Mechanistic Assessment. Pharmaceutics 2022;14:1789. [DOI: 10.3390/pharmaceutics14091789] [Reference Citation Analysis]
2 Zhao Y, Antunes A. Biomedical Potential of the Neglected Molluscivorous and Vermivorous Conus Species. Marine Drugs 2022;20:105. [DOI: 10.3390/md20020105] [Reference Citation Analysis]
3 Tsetlin V, Haufe Y, Safronova V, Serov D, Shadamarshan P, Son L, Shelukhina I, Kudryavtsev D, Kryukova E, Kasheverov I, Nicke A, Utkin Y. Interaction of α9α10 Nicotinic Receptors With Peptides and Proteins From Animal Venoms. Front Cell Neurosci 2021;15:765541. [PMID: 35002625 DOI: 10.3389/fncel.2021.765541] [Reference Citation Analysis]
4 Dyachenko IA, Palikova YA, Palikov VA, Korolkova YV, Kazakov VA, Egorova NS, Garifulina AI, Utkin YN, Tsetlin VI, Kryukova EV. α-Conotoxin RgIA and oligoarginine R8 in the mice model alleviate long-term oxaliplatin induced neuropathy. Biochimie 2021:S0300-9084(21)00301-1. [PMID: 34979156 DOI: 10.1016/j.biochi.2021.12.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yousuf A, Wu X, Bony AR, Sadeghi M, Huang YH, Craik DJ, Adams DJ. ɑO-Conotoxin GeXIVA isomers modulate N-type calcium (CaV 2.2) channels and inwardly-rectifying potassium (GIRK) channels via GABAB receptor activation. J Neurochem 2021. [PMID: 34738241 DOI: 10.1111/jnc.15535] [Reference Citation Analysis]
6 Guo M, Yu J, Zhu X, Zhangsun D, Luo S. Characterization of an α 4/7-Conotoxin LvIF from Conus lividus That Selectively Blocks α3β2 Nicotinic Acetylcholine Receptor. Mar Drugs 2021;19:398. [PMID: 34356823 DOI: 10.3390/md19070398] [Reference Citation Analysis]
7 Gajewiak J, Christensen SB, Dowell C, Hararah F, Fisher F, Huynh PN, Olivera BM, McIntosh JM. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism. J Med Chem 2021;64:9271-8. [PMID: 34142837 DOI: 10.1021/acs.jmedchem.1c00512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Shi X, Bai H, Wang J, Wang J, Huang L, He M, Zheng X, Duan Z, Chen D, Zhang J, Chen X, Wang J. Behavioral Assessment of Sensory, Motor, Emotion, and Cognition in Rodent Models of Intracerebral Hemorrhage. Front Neurol 2021;12:667511. [PMID: 34220676 DOI: 10.3389/fneur.2021.667511] [Reference Citation Analysis]
9 Li Z, Han X, Hong X, Li X, Gao J, Zhang H, Zheng A. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2]. Mar Drugs 2021;19:121. [PMID: 33668830 DOI: 10.3390/md19030121] [Reference Citation Analysis]
10 Kawashiri T, Mine K, Kobayashi D, Inoue M, Ushio S, Uchida M, Egashira N, Shimazoe T. Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence. Int J Mol Sci 2021;22:1393. [PMID: 33573316 DOI: 10.3390/ijms22031393] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Carroll AR, Copp BR, Davis RA, Keyzers RA, Prinsep MR. Marine natural products. Nat Prod Rep 2021;38:362-413. [PMID: 33570537 DOI: 10.1039/d0np00089b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
12 Li X, Tae HS, Chu Y, Jiang T, Adams DJ, Yu R. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor. Pharmacol Ther 2021;222:107792. [PMID: 33309557 DOI: 10.1016/j.pharmthera.2020.107792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Dos Santos E, Radai JAS, do Nascimento KF, Formagio ASN, de Matos Balsalobre N, Ziff EB, Castelon Konkiewitz E, Kassuya CAL. Contribution of spathulenol to the anti-nociceptive effects of Psidium guineense. Nutr Neurosci 2020;:1-11. [PMID: 32912110 DOI: 10.1080/1028415X.2020.1815330] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pellacani C, Eleftheriou G. Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies. Adv Med Sci 2020;65:265-85. [PMID: 32361484 DOI: 10.1016/j.advms.2020.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
15 Huynh PN, Harvey PJ, Gajewiak J, Craik DJ, Michael McIntosh J. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors. Biochem Pharmacol 2020;181:114124. [PMID: 32593612 DOI: 10.1016/j.bcp.2020.114124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Herzig V, Cristofori-Armstrong B, Israel MR, Nixon SA, Vetter I, King GF. Animal toxins - Nature's evolutionary-refined toolkit for basic research and drug discovery. Biochem Pharmacol 2020;181:114096. [PMID: 32535105 DOI: 10.1016/j.bcp.2020.114096] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
17 Sun Z, Bao J, Zhangsun M, Dong S, Zhangsun D, Luo S. αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors. Mar Drugs 2020;18:E195. [PMID: 32272701 DOI: 10.3390/md18040195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Xu P, Kaas Q, Wu Y, Zhu X, Li X, Harvey PJ, Zhangsun D, Craik DJ, Luo S. Structure and Activity Studies of Disulfide-Deficient Analogues of αO-Conotoxin GeXIVA. J Med Chem 2020;63:1564-75. [DOI: 10.1021/acs.jmedchem.9b01409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Sun Z, Zhangsun M, Dong S, Liu Y, Qian J, Zhangsun D, Luo S. Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA. Mar Drugs 2020;18:E61. [PMID: 31963558 DOI: 10.3390/md18010061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Huynh PN, Giuvelis D, Christensen S, Tucker KL, McIntosh JM. RgIA4 Accelerates Recovery from Paclitaxel-Induced Neuropathic Pain in Rats. Mar Drugs 2019;18:E12. [PMID: 31877728 DOI: 10.3390/md18010012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Oroz-Parra I, Álvarez-Delgado C, Cervantes-Luevano K, Dueñas-Espinoza S, Licea-Navarro AF. Proapoptotic Index Evaluation of Two Synthetic Peptides Derived from the Coneshell Californiconus californicus in Lung Cancer Cell Line H1299. Mar Drugs 2019;18:E10. [PMID: 31861952 DOI: 10.3390/md18010010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]